These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21549850)

  • 1. Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?
    Betts BC; Young JA; Ustun C; Cao Q; Weisdorf DJ
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1562-8. PubMed ID: 21549850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
    Dulery R; Salleron J; Dewilde A; Rossignol J; Boyle EM; Gay J; de Berranger E; Coiteux V; Jouet JP; Duhamel A; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1080-9. PubMed ID: 22212513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34
    Huang YT; Kim SJ; Lee YJ; Burack D; Nichols P; Maloy M; Perales MA; Giralt SA; Jakubowski AA; Papanicolaou GA
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1759-1766. PubMed ID: 28668490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.
    de Koning C; Admiraal R; Nierkens S; Boelens JJ
    Blood Adv; 2018 Feb; 2(4):428-432. PubMed ID: 29487057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.
    Winestone LE; Punn R; Tamaresis JS; Buckingham J; Pinsky BA; Waggoner JJ; Kharbanda S
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29181879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
    Hill JA; Nichols WG; Marty FM; Papanicolaou GA; Brundage TM; Lanier R; Zerr DM; Boeckh MJ
    Blood; 2020 Apr; 135(17):1447-1451. PubMed ID: 32076716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of PCR detection of HHV6 in gastro biopsy on the course of diarrhea in patients with severe diarrhea after allogeneic hematopoietic stem cell transplantation].
    Han TT; Zhao XS; Huang XJ; Zhang XH; Liu KY; Wang Y; Yan CH; Xu LP
    Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):690-694. PubMed ID: 28954348
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of human herpes virus 6 infections with a quantitative, standardized, commercial kit in pediatric stem cell transplant recipients after transplantation.
    Mutlu D; Uygun V; Yazisiz H; Tezcan G; Hazar V; Colak D
    Ann Saudi Med; 2014; 34(1):6-11. PubMed ID: 24658548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.
    Zerr DM; Boeckh M; Delaney C; Martin PJ; Xie H; Adler AL; Huang ML; Corey L; Leisenring WM
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1700-8. PubMed ID: 22641196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
    Tokimasa S; Hara J; Osugi Y; Ohta H; Matsuda Y; Fujisaki H; Sawada A; Kim JY; Sashihara J; Amou K; Miyagawa H; Tanaka-Taya K; Yamanishi K; Okada S
    Bone Marrow Transplant; 2002 Apr; 29(7):595-8. PubMed ID: 11979309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
    Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
    Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
    J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.
    Toriumi N; Kobayashi R; Yoshida M; Iguchi A; Sarashina T; Okubo H; Suzuki D; Sano H; Ogata M; Azuma H
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):379-83. PubMed ID: 23929317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of valganciclovir
    Zhu J; Xu M; Ru Y; Gong H; Ding Y; Zhu Z; Xu Y; Fan Y; Zhang X; Tu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Song T; Wu D; Chen J
    Leuk Lymphoma; 2024 Jun; 65(6):816-824. PubMed ID: 38475670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.
    Olson AL; Dahi PB; Zheng J; Devlin SM; Lubin M; Gonzales AM; Giralt SA; Perales MA; Papadopoulos EB; Ponce DM; Young JW; Kernan NA; Scaradavou A; O'Reilly RJ; Small TN; Papanicolaou G; Barker JN
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):787-93. PubMed ID: 24548875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients.
    Pawlowska AB; Karras NA; Liu H; DiMundo J; Cheng JC; Sun W; Armenian S; Yang D; Palmer JM; Bell A; Tahoun A; Tegtmeier B; Dadwal S; Rosenthal J
    Transpl Infect Dis; 2021 Feb; 23(1):e13453. PubMed ID: 32860467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation.
    Violago L; Jin Z; Bhatia M; Rustia E; Kung AL; Foca MD; George D; Garvin JH; Sosna J; Robinson C; Karamehmet E; Satwani P
    Pediatr Transplant; 2015 Nov; 19(7):737-44. PubMed ID: 26329541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.